Spark Investment Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-760
Closed -$188K 720
2018
Q1
$188K Buy
760
+312
+70% +$77.2K 0.01% 513
2017
Q4
$60K Sell
448
-1,232
-73% -$165K ﹤0.01% 653
2017
Q3
$207K Buy
1,680
+1,112
+196% +$137K 0.01% 603
2017
Q2
$54K Buy
+568
New +$54K ﹤0.01% 742
2017
Q1
Sell
-480
Closed -$52K 888
2016
Q4
$52K Buy
+480
New +$52K ﹤0.01% 741